chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joints in hands began to hurt then wrists and right hip joint. Pain lasted through the weekend and continues at this time. Treating with NSAIDS and rest.
I started to have symptoms of headache, never had a fever but I did sweat off and on, I had cough, runny nose and extreme fatigue for a couple of days starting on 01/06/2022. I couldn't get an appointment so I went to Dr.'s office and tested positive for Covid on 01/10/2022. Dr. did not prescribe anything. After that I had worsening of the same symptoms for about seven days. I just slept constantly.
Chills, shaking, nausea, throwing up, weak, blood pressure went up. Dr. gave pills for nausea and then she slept. Called Dr. on call for Dr.
Information has been received from an investigator via agency concerning a patient with HIV infection who was enrolled in a study. On an unspecified date, the patient was vaccinated with PNEUMOVAX 23 (manufacturer unknown) and RECOMBIVAX HB. On an unspecified date, one week after vaccination, the patient experienced immunization/vaccine reaction. The reporting investigator felt that immunization/vaccine reaction was related to therapy with PNEUMOVAX 23 and not related to therapy with RECOMBIVAX HB. Immunization/vaccine reaction was considered to be an other important medical event.
Eye discomfort; This is a spontaneous report from a non - contactable other healthcare professional. A 60-years-old female patient received a single dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE ) ( Lot number = not known ) via an unspecified route of administration in left arm on 11Mar2021 ( at the age of 60-years-old ) at 09:45am as a first dose for COVID-19 vaccination. Medical history included that patient was diabetic. Since the vaccination patient had not been tested for covid-19. The patient had took diabetic medicines as a concomitant medications within two weeks of vaccination. The patient did not received any other vaccine within four weeks prior to the vaccination. On 12Mar2021, after 24 hours post vaccination the patient experienced discomfort in the ocular eye. Patient did not experienced any pain. The outcome of this reaction is not recovered. Information about lot/batch number cannot be obtained and no further information is expected.
Pt rcv'd vax on 10/27/98. Exposed to chicken pox 12/99 and develop full case of chicken pox. After 10 days vax was ineffective.
The adverse event was a breakthrough infection of COVID.  Sore throat, cough, runny nose, loss of smell and low grade fever.  Prescribed benzonatate for cough on July 9, 2022.
Engerix-B - Safety of extra dose; patient received a second dose of Boostrix on; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 18-year-old male patient who received HBV (Engerix B) (batch number DD7K7, expiry date 31-MAR-2024) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Boostrix (received 1st dose when patient was 12 year old).   On 31-MAY-2023, the patient received the 4th dose of Engerix B and the 2nd dose of Boostrix. On 31-MAY-2023, an unknown time after receiving Engerix B and not applicable after receiving Boostrix, the patient experienced extra dose administered (Verbatim: Engerix-B - Safety of extra dose) and drug dose administration interval too short (Verbatim: patient received a second dose of Boostrix on). The outcome of the extra dose administered and drug dose administration interval too short were unknown.   Additional Information: GSK Receipt Date: 30-JUN-2023 The same day the patient received a second dose of Boostrix with 4th dose of Engerix-B.  The healthcare professional asked for safety information. According to healthcare professional, the patient had not reported any adverse reaction following the vaccination. The reporter consented to follow up. The patient received 2nd dose of Boostrix (booster) earlier than the recommended schedule, which led to shortening of vaccination schedule. The patient was administered with a fourth dose of Engerix-B, which led to extra dose administered.
I felt fine until the second shot on Saturday, I awoke to excruciating in my groin and hip of my right leg, I had 2 ultrasounds, an X-Ray and a CT scan, these all showed negative. I am seeing an osteopathic doctor who is having difficulty diagnosing my pain. it has been 5 weeks of constant pain that I've never had before, before that 2nd shot I felt perfectly healthy.
10 mins after pt. received vaccines pt. c/o feeling faint.  Pt. became pale & clammy but did not faint.
STORAGE IN REFRIGERATOR ( 2 °c -8°c ) up  to 30 days.  (vaccine used after 10-16-2021)
Fever Chills Body aches  Headache Lymph node swelling under injection site arm
Woke up the next morning after receiving the vaccine, and felt horrible.  Fever 101, aches, chills.  Was only out of bed for a couple of minutes, knew that something was not right, and then I passed out on the floor for at least 15 minutes.
Pt has a low grade temp and area of erythema measuring 7.5 x 10 cm around the area where immunizations were given in the (R) thigh. KEFLEX 125mg/5ml x 5 days. BENADRYL OTC.
Patient nearly fainted, first Blood Pressure 62/48 Pulse 47. Given apple juice and Patient's mother was called. Second Blood Pressure 93/50 Pulse 60.
tired; Nausea; weak; left arm hurts; dizzy; Headache; feels numb; This is a spontaneous report from a contactable consumer (patient herself). A 71-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6198), via an unspecified route of administration on 04Mar2021 (at the age of 71-years-old), as 2nd dose, single in left arm for COVID-19 immunization. The patient's medical history included irritable bowel syndrome which was diagnosed a few years ago, lost some weight last year in 2020, like 50 pounds, but now she was gaining weight. Concomitant medication included levothyroxine sodium (UNITHROID) 50mg, taken every day except one day of the week, for an unspecified indication, start and stop date were not reported and vitamins.  The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FL9269) via an unspecified route of administration on 11Feb2021 (at the age of 71-years-old), as single dose for COVID-19 immunization and experienced adverse reaction. The patient's past medication also included some vitamins, and cipro [CIPROFLOXACIN] from which she experienced adverse drug reaction. On 04Mar2021, after taking the second shot, the patient experienced, headache, she put ice on her head and the headache went away and it feels better, she didn't take Tylenol, but it feels numb. She felt, dizzy and her left arm hurts. On 05Mar2021, the patient woke up weak, nauseous and tired. Her arm hurt a little but she put ice on it. The patient said her nausea went away and that her weakness comes and goes. The patient's left arm hurt where the vaccine was, ice had helped. The patient also mentioned that after she had the vaccine, on the way home she felt dizzy but it went away. The patient stated that she knows there are some side effects for the vaccine, she had a general reaction with the first dose, she thinks today is a little bit stronger this time. The patient had ginger tea for nausea. The patient also wanted to know whether this was normal. The patient enquired about pain reliever use, multivitamin, walking/yoga. The clinical outcome of the event nausea and dizzy was resolved, the outcome of headache and left arm hurts was resolving. The outcome of the event weak and tired was not resolved and the outcome of event feels numb was unknown.
headache, body aches , teeth  hurt  patient took Tylenol and her Butal acet caff, sumatriptan. Asking if she can take her Ambien?. Advised yes, take medications as prescribed/directed  4/15-Patient returned call, no signs and symptoms at this time. Body aches, headache and teeth pain lasted 2 days after receiving vaccine, has taken Butal acetaminophen caffeiene to relieve symptoms
broke out with hives on her face and hands; Swollen lymph nodes in throat; This is spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in left arm on 25Mar2021 16:30 (Batch/Lot Number: ER8732) (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included benign brain tumor removal, seizures (previous seizures prior to surgery), penicillin (PCN) allergy and sulfa drugs allergy. Concomitant medications included topiramate (TOPAMAX), eletriptan hydrobromide (RELPAX), ergocalciferol (VITAMIN D) and ascorbic acid (VITAMIN C), all were taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient broke out with hives on her face and hands and had swollen lymph nodes in throat on 27Mar2021 08:00. The patient went to emergency room/ department or urgent care due to the events, broke out with hives on her face and hands and swollen lymph nodes in throat. The patient received antihistamine as the treatment for the events, broke out with hives on her face and hands and swollen lymph nodes in throat and the patient was also offered steroid but she declined it. The outcome of events, broke out with hives on her face and hands and swollen lymph nodes in throat, was recovering.  No follow-up attempts are needed. No further information is expected.
small hive on lower legs < 1/2" in diameter; approx a total of 10 on both legs; no other sx lasted 5-6 days;
an approx 2mmx10mm (long narrow) blister present @ site of inj some sl redness & swelling also noted;has not gone to MD however does plan to if blister get any larger;
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 17-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength: 0.5ml)(lot # L036245, expiration date 09-FEB-2018). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer)(R/F) for each time were 136, 33 and R; 40, 34 and R. The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
Within 5 minutes after receiving the shot, patient started having headache & heartache on and off for about 10 minutes. Patient also complaint about his throat/mouth was dry.  15 minutes after he started to have numbness around his mouth and on tip/ middle part of his tongue. Numbness lasted for about half an hour. That night he vomited and has chills. Next day he had very mild fever, pain in the right lung when he sneezed / coughed. He didn't have much symptoms on the 3rd day except for an sore arm and tireness.
I was vaccinated with Tdap at my doctor's office.  That evening I started experiencing redness, swelling and pain shooting from my wrist to my shoulder.  It took a month and a half for the redness and swelling to go away.  I am still in chronic pain.  Sometimes I cannot sleep very well.  I visited my chiropractor mid August and she gave me some supplements.  They helped a little bit, but I am still in pain.  My ligaments are painful in general all over my body.  I didn't have this problem prior to the injection.
Patient presents with complaint(s) of fever 102-103 fevers, rash all over, lymph node in groin the size of a pea x 3 days. 102.4 fever in office. Onset three days ago. No real rhinorrhea-other than when crying. Had an appointment for well visit but was fine. MMR given in left leg at that time. Now with enlarged lymph node left femoral/inguinal-no inflammation-non-tender. Vomits with Ibuprofen-no Acetaminophen yet today 9/6/12. Plan: Treat to cover strep in light of pharyngitis. Strongly suspect sequelae to MMR vaccination - does not follow course of events or characteristics of rash of roseola. Monitor closely in light of high fever. Coun/Edu: Discussed viral exanthem vs. sequelae of MMR vaccine-handout re: MMR vaccination with possible rash/fever within 7-12 days of vaccination. Discussed cover for strep in light of pharyngitis and recent increase in strep pharyngitis seen. Symptomatic treatment and usual course discussed. Reviewed fever and pain control with tylenol. Instructed to call or return for: --Symptoms not improved in 2 days, --Worsening symptoms, --New, unexplained symptoms develop.
REVACCINATION WITH DIFFERENT COVID-19 VACCINE; REBOUND COVID INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: sleep apnea, penicillin allergy, and drug allergy (quinine). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805029 expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-MAR-2021 in right arm for covid-19 prophylaxis. Age at time of vaccination 62 years old. Concomitant medications included acetylsalicylic acid, allopurinol, carvedilol, ergocalciferol, hydrochlorothiazide, krill oil, lisinopril, magnesium, rabeprazole, rosuvastatin, tamsulosin, testosterone, ubidecarenone, and vitamin b complex.  It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient additionally received two doses of non-company suspect vaccine included: Moderna covid-19 vaccine (elasomeran) (dose number in series 2) (form of admin, and route of admin were not reported, batch number: 939906 expiry: UNKNOWN) dose was not reported, second dose administered on 23-OCT-2021 and (form of admin, and route of admin were not reported, batch number: 065K21A expiry: UNKNOWN) dose was not reported, third dose administered on 04-APR-2022 in right arm for covid-19 prophylaxis. It was unknown whether patient had any adverse event following vaccination with two doses of Moderna covid-19 vaccine (elasomeran) (dose number in series 2). The patient additionally received fourth dose of non-company suspect vaccine included: Moderna covid-19 vaccine (elasomeran) (dose number in series 3) (form of admin, and route of admin were not reported, batch number: AS7144B expiry: UNKNOWN) dose was not reported, administered on 10-SEP-2022 14:00 in right arm for covid-19 prophylaxis. Patient was revaccinated with different covid-19 vaccine (dose number in series 3). On an unspecified date in 2022, the patient experienced covid-19 (dose number in series 3). The patient received non-company co-suspect drug Paxlovid (form of administration, route of administration, batch number, and expiry were not reported) dose was not reported, administered from 08-OCT-2022 to 14-OCT-2022 for treatment of COVID-19. On 11-OCT-2022, Patient experienced rebound covid infection. The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and elasomeran was not applicable. The patient was recovering from rebound covid infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.
chills in the early saturday morning shaking in bed  .   Head ache in the morning, fever on 100.4  No  balance.   Took two tylenols and fever went down and still not very sturdy on feet.  next day felt better but had night sweats and had to change shirts.  Night sweat saturday night in to sunday morning.  Feeling ok on sunday.   The systems are the same as having covid 19 when he had it.
Vaccine details unknown, lot number, bivalent, etc. fever, headache, arm pain, visual hallucinations ED evaluation mild leukocytosis otherwise unrevealing Patient discharged home for outpatient follow up
Extremely hot with a slight temperature, headache, neck pain, headache, cold hands and feet, lightheaded, weak limbs, and some trouble breathing.
Information has been received from a female who, on an unspecified date, was vaccinated with Zostavax and an influenza virus vaccine (unspecified).  No information was provided with regard to the patient's medical history and concomitant therapy.  Subsequently the patient experienced dizzy spells and vomiting.  The patient did not seek medical attention.  The patient noted she got the vaccines administered at the same time so she did not know which vaccine made her feel that way.  The patient outcome was not provided.  Additional information has been requested.
18JUN91 Pt recd 1st dose (? 20mcg); about 5 days p/vax Pt developed itching, red areas in groin, elbows, behind knees; as of 1JUL91 condition is persisting; no rx given; given;
3MAR92 recvd a booster dose of Engerix-B; 5MAR92 ? lump devel @ inject site (lt deltoid); 16MAR92 ? aching, shooting, pain lt arm to neck devel;
Subject in pneumococcal vaccine trial, with severe COPD, was hospitalized with COPD exacerbation. Vaccination took place on 1/02/2008. According to the physician, the relationship is 'None'. We would be happy to forward the Study's SAE Reporting Form upon request.
Breakthrough COVID. First vaccine 1/22/2021. 70-year-old male A staff member in the nursing home was positive for COVID-19 and passed it on to multiple patient is in the nursing home.  The patient was brought in for shortness of breath and hypoxemia.  He was poorly responsive an ABG showed acute hypercapnic respiratory failure.  He was intubated.  he patient underwent PEA arrest. Preliminary cause of death: Cardiac arrest.  Due to: COVID-19.
Nausea started around 11 am on day after vaccination, followed by fever and fatigue, with chills and loss of appetite. Mild-moderate headache as well. I slept the entire day, eating little. Fever continued throughout the day and night. Fever up to 103.3. Less fatigue on the next day (the 15th) and temp started at 99.8 but then increased to 100-101.8. Mild-moderate headache. Slept and rested most of the day, unable to perform normal routine. By the 16th no fever and felt well.
I received the 2nd dose of the Moderna Vaccine for Covid 19 at 2:15 pm on 4/23/21.  I woke up on 4/24/21 around 4:15 am with the following adverse reactions:  103* temperature, extreme body aches and muscle pain, a headache, a fast heartbeat and chills.  I took Tylenol every 4-6 hours until the reactions subsided on Sunday afternoon (4/25/21).
Fever; Severe headache; Chills; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever), HEADACHE (Severe headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEADACHE (Severe headache) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), HEADACHE (Severe headache) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   This case was linked to MOD-2021-003538 (Patient Link).   Reporter did not allow further contact
A 40 year old female patient was received in the COVID-19 vaccination are in the Hospital for the second dose PFIZER vaccine accompanied by her two children. At the time of collection all the information the patient informs having an allergic reaction to her first COVID-19 PFIZER vaccine dose. She refers "after administering my first dose vaccine PFIZER I started a week later with a severe pain in my right ovary with a lot of bleeding, clots and bad odor. My period was about to come and it is always regular, and it was not the time yet, I think this happened to my because of the vaccine" It was recommended that the patient visits her primary physician before administering her the second dose. She expressed and authorizes the administration of the second dose and signs the consent. She is advised in case of bleeding again, to visit the nearest emergency room and she understands. The second dose was administered with accepted measures. the patient had no adverse reaction during the 15 minute wait and returns home.
This spontaneous report as received from a certified medical assistant refers to a 15 month old patient with no pertinent medical history, drug allergies or reactions reported. On 27-FEB-2015, the patient was vaccinated with the first dose of VAQTA (dose, lot number and expiration date were not provided) intramuscular. On 05-JUN-2015, the patient was vaccinated with a second dose of VAQTA (dose, lot number and expiration date were not provided) intramuscular. Concomitant therapy was not reported. No known adverse effects reported. Additional information has been requested.
GAIIT UNSTEADY,NUMBNESS OF HANDS, LACK OF DEXTERITY IN FINGERS, TIGHT BAND UNDER BREAST EXTENDING TO BACK. WAS HOSPITALIZED IN JANUARY 23,2022 AS SYMPTOMS GOT WORSE. WAS ON STEROIDS AND PAIN MEDICATION , HAD CAT SCANS OF BACK,HEAD,SPINAL TAP, MULTIPLE BLOOD WORK. STILL HAVE SAME SYMPTOMS FOR OVER A YEAR.
Extreme fatigue persisting 7 days post vaccination.  Arm in which vaccination was administered is still sore.  The arm was initially "swollen" but that has gone down and patient denies redness or heath in that arm.
This spontaneous report as received from a medical assistant refers to two unspecified patients of unknown age and gender. There was no information about the patients' pertinent medical histories, concomitant medications and drug reactions or allergies reported. On an unknown dates, the two patients were vaccinated with an improperly stored doses of VAQTA (lot# L018499, expiration date 25-FEB-2017, dose, anatomical location and route of administration were not reported). No adverse effects were reported. Temperature was 34.9 Fahrenheit with time frame 3 hours data logger was involved and there was no previous temperature excursion reported. This is one of several reports received from the same reporter. Additional information has been requested.
Allergic reaction in medium hives on the left arm, the hives are hot and itchy.
Narrative: Patient contacted telephone triage nurse today requesting advice. Patient states he had first moderna vaccine yesterday and feels he is having a bad reaction to it. Patient states he felt okay last night, "a slight headache", went to bed - woke up with a "Very bad headache" this morning. Pt states head is aching in the back "Right above the neck, just throbbing - and my eyes are hurting very, very bad, and I had a fever." No confusion, blurred vision, facial droop, unilateral weakness, difficulty swallowing or other s/s CVA. No rashes, cough, chest congestion or abdominal pain. Temperature = 102.2 at this time. Unable to obtain accurate B/P reading (reads "error" repeatedly - even when repositioned, but works on his wife's arm, so not a cuff issue).